According to a new report, two patients with Dystonia were freed from the severe debilitating effects of the disease through deep brain stimulation therapy, continued to have symptom relief for months after their devices accidentally were fully or partly turned off.
Researchers have given rats the ability to “touch” infrared light by fitting them with an infrared detector wired to microscopic electrodes implanted in the part of the mammalian brain that processes tactile information. The study demonstrated that a novel sensory input could be processed by a cortical region specialized in another sense without “hijacking” the function of this brain area.
A new study discovers mice can recover from physically debilitating strokes that damage the primary motor cortex, if the rodents are quickly subjected to physical conditioning that rapidly “rewires” a different part of the brain to take over lost function.
A training regimen to adjust the body’s motor reflexes may help improve mobility for some people with incomplete spinal cord injuries. During training, the participants were instructed to suppress a knee jerk-like reflex elicited by a small shock to the leg. Those able to calm hyperactive reflexes saw improvements in their walking.
A new study reveals DCC, the receptor for a crucial protein in the nervous system known as netrin, plays a key role in regulating the plasticity of nerve cell connections in the brain.
New research discovers an early step in how the brain’s inhibitory cells get excited. Erbin, a protein critical to brain development, is also crucial for the excitement of inhibitory cells.
A recent study indicates microRNAs may play a far more important role in memory formation than previously thought. The research suggests microRNA—miR-182 is involved in developing memory in the amgydala.
A protein associated with neuron damage in Alzheimer’s patients provides a superior scaffold for growing central nervous system cells in the lab.
Doctors performed the first-ever FDA approved Schwann cell transplantation in a patient with a new spinal cord injury. The procedure is a Phase 1 clinical trial designed to evaluate the safety and feasibility of transplanting the patient’s own Schwann cells.
Researchers report that low blood and oxygen flow to the developing brain does not, as previously thought, cause an irreversible loss of brain cells, but rather disrupts the cells’ ability to fully mature.